Navigation Links
ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
Date:12/1/2008

se and other non-clinical activities into 2008 will enable a more rapid and continuous development path into Phase II studies during 2009.

Clinical Need and Market Opportunity in HCV Infection

Chronic HCV infection is a serious public health concern affecting approximately 3.2 million people in the United States and approximately 170 million people worldwide. HCV causes inflammation of the liver, which can lead to fibrosis and cirrhosis, and may ultimately lead to liver failure and/or liver cancer if not successfully treated. Cirrhosis of the liver resulting from chronic HCV infection is the leading indication for liver transplantation in the U.S. Due to the asymptomatic nature of HCV infection, it often goes undetected for up to 20 years following initial infection. Each year, 8,000 to 10,000 people in the U.S. die from complications of HCV.

The current standard of care is a combination of pegylated interferon and ribavirin. Inadequate response rates, in particular for patients infected with genotype 1 HCV, along with significant side effects of approved therapy, support the medical need for improved treatment options. It is estimated that fewer than 5% of people with chronic HCV infection living in the U.S. are under treatment today. Most infected individuals are unaware of their infection status and the large majority of individuals who know their condition do not currently receive drug therapy. There is also a growing number of individuals who have failed interferon-based regimens who may be successfully treated with combinations of two or more direct antivirals. It is expected that the next generation of therapies for treatment of HCV will include small molecules, such as ANA598, that directly act upon specific viral enzymes to inhibit viral replication. These new therapies are expected to improve overall therapy by increasing cure rates and potentially improving toler
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...o,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesCan...ds,adivisionofThompsonsLimitedofBlenheim,Ontario.T...ences,currentseedsbusinessasthecompanyanticipatest...oSciencesHerbicideTolerantTraitTechnologyincornin2.... ,, "Thisacquisitionbringstogethertwostrongpro...
(Date:11/24/2009)... care employment grew by 29,000 jobs in October, ...ent growth during the U.S. recession. However, cli...d health systems are coming closer to having to ac...nistrators. , (Vocus) Nov... growing in October despite the shedding of jobs i...
(Date:11/24/2009)...Newswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX )...mmercializingnovelpainmanagementtherapies,announce...eOfficer,isscheduledtopresentatthe21stAnnualPiperJ...9atTheNewYorkPalaceHotelinNewYork,NewYork. ,, M...,willbeavailabletorespondtoquestionsduringtheprese...
(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...erage technologies for PACS data disaster recovery...anagement (IKM) business unit of Siemens Healthcar...s Corporation ( www.harris.com ) are joining...olutions critical for Picture Archiving and Commun...t business continuity. , , (Logo: http://www...
...Verenium Corporation (Nasdaq: VRNM ), a pioneer ...nzymes and next-generation cellulosic ethanol, tod...ioning of Verenium,s demonstration-scale facility ...t of a commercial joint venture with BP, Verenium ...(R&D) organization, including the pilot and de...
...Pharmaceuticals, Inc. (Nasdaq: AMLN ) today rele...t Director, James N. Wilson, providing shareholder... Fellow Amylin Shareholder: , , As Lead Independe...rovide a summary of exciting business developments...of highly qualified and experienced individuals we...
Other Biology Technology:Siemens Healthcare Announces Planned Collaboration with Harris Corporation 2Siemens Healthcare Announces Planned Collaboration with Harris Corporation 3Siemens Healthcare Announces Planned Collaboration with Harris Corporation 4Verenium Announces Organizational Changes 2Verenium Announces Organizational Changes 3Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 2Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 3Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 4Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 5Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 6Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 7Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments 8
(Date:11/23/2009)...edical engineer and cardiologist Tzung "John" Hsia...istinguish cardiac emergencies requiring immediate...gs and lifestyle change. , Angiograms, images ma... the heart, offer an inside view of the interior s...ealing deposits of a dangerous fatty substance cal...
(Date:11/23/2009)..., , , , , , , ,...rew Marshall, from the Environment Department at t... Kinyongia magomberae and his wider work in Tanza...rmation. , , , , , , ... , , , , A new species of chameleon has...
(Date:11/23/2009)...itute for Child Health Research has found evidence... in pregnancy affects child behaviour in different...e in the international journal Addiction . , Le...awn from a random sample of more than 2000 mothers...the baby,s delivery, and were then followed up whe...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3New study links alcohol in pregnancy to child behavior problems 2Finding key to cancer drug Gleevecs limitations 53747 1Finding key to cancer drug Gleevecs limitations 53747 2Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 1Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 2Dartmouth gets 243 million from the National Science Foundation for IT research in health care 53743 3Joint research into an enzyme that causes genetic diseases 9486 1
...or alcohol has yielded a rapid, inexpensive way to... beat cops keeping misguided cells from attacking ...ers of these cells opens the door to improved trea...eases such as type 1 diabetes and arthritis, Medic... are components of the immune system designed to a...
...in which the enzyme RNA polymerase constructs chai...ds upon previously underappreciated sections of bo...ording to work done with the bacterium E. coli and...a team of bacteriologists from the University of W...ut a key step in RNA synthesis has important impli...
...r bodies are replaced through cell division. Resea... of the puzzle of how genetic information remains ...Their results are presented in the latest issue of...t human consists of about 50,000 billion cells, 1%...ery day. In order to ensure cell survival and cont...
Other Biology News:Finding paves way for better treatment of autoimmune disease 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 3A protein complex that untangles DNA 2
UCB MNC Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
CD8 T Cell Chip-IHC from 3H Biomedical AB
...pecifically for the stabilization of adsorbed or i...oating Stabilizer maintains the conformation and a... of the dried immunoassay components. Product is ...tein-containing stabilizer and blocking solution i...
Biology Products: